Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01195116 · ClinicalTrials.gov registry record · Phase 4
Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis
A Phase 4 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT01195116 is a Phase 4 study that has completed, run by University of Rochester. The registered enrollment target is 41 participants.
The verdict
NCT01195116, a Phase 4 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effects of dexmedetomidine while patients undergo treatment for Interstitial Cystitis (IC). The investigators goal is to demonstrate in patients with IC undergoing bladder hydrodistension that the use of dexmedetomidine as a supplemental anesthetic agent will result in better postoperative pain management.
Interventions
- DRUG Dexmedetomidine
- DRUG Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01195116
The ClinicalTrials.gov registry entry for NCT01195116 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT01195116 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01195116 about?
NCT01195116 is a clinical study titled "Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis". The purpose of this study is to assess the effects of dexmedetomidine while patients undergo treatment for Interstitial Cystitis (IC). The investigators goal is to demonstrate in patients with IC undergoing bladder hydrodistension that the use of dexmedetomidine as a supplemental anesthetic agent wi...
What is the current status of trial NCT01195116?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2010-05. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01195116?
The interventions under investigation include: Dexmedetomidine (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT01195116?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.